Nogo-B 水平与糖尿病足感染相关性研究
Levels of Nogo-B in patients with diabetic foot infection: a retrospective study
研究发现,糖尿病足感染患者血清中 Nogo-B 水平低于无感染患者(18.66 ± 4.16 ng/ml vs 26.77 ± 3.27 ng/ml,P < 0.001)。
- Laurent Irakoze1,2,
- Astère Manirakiza1,
- Prudence Bizimana1,3,
- Jean Claude Nduwayezu1,
- Charles Niyomugisha1,
- Paul Banderembako1,
- Martin Manirakiza1,
- Desire Nisubire1,
- Liliane Nkengurutse4,
- Guixin Chen2 &
- …
- Qingfeng Cheng ORCID: orcid.org/0009-0008-9522-17252
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Nogo-B has been implicated in many metabolic diseases including diabetes mellitus. It is still unclear whether the levels of serum Nogo-B decrease in patients with diabetic foot infection (DF). We retrospectively collected sera of T2DM patients with or without DF from the First Affiliated Hospital of Chongqing Medical University. Human Nogo-B ELISA Kit (Jiubang Biotechnology Cat number: QZ-17338) was used to determine serum Nogo-B levels in all the samples. Graphpad and SPSS version 27 software were used for statistical analyses. T2DM patients with DF displayed lower levels of Nogo-B than those without DF (18.66 ± 4.16 ng/ml versus 26.77 ± 3.27 ng/ml, respectively; P < 0.001). In addition, lower levels of Nogo-B were associated with DF [OR (95% CI) = 0.528 (0.436–0.640), P < 0.001]. This association was independent of other factors associated with DF [OR (95% CI) = 0.413 (0.244–0.702), P = 0.001). The results of our study highlight the association of lower levels of Nogo-B with DF. Our findings describe associations and cannot establish causation. Future studies should be conducted to verify or confirm our findings.
Acknowledgements
The authors thank John Belly for his important advice.
Funding
National Natural Science Foundation of China Grants (81871222 and 81570763) supported the study.
Author information
Authors and Affiliations
Department of Internal Medicine, Affiliated Hospital of Burundi University (Roi Khaled), Bujumbura, Burundi
Laurent Irakoze, Astère Manirakiza, Prudence Bizimana, Jean Claude Nduwayezu, Charles Niyomugisha, Paul Banderembako, Martin Manirakiza & Desire Nisubire
Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China
Laurent Irakoze, Guixin Chen & Qingfeng Cheng
National Institute of Public Health, Bujumbura, Burundi
Prudence Bizimana
Ministry of Public Health and Fighting AIDS, Epidemiological Emergency Service, Bujumbura, Burundi
Liliane Nkengurutse
Authors
- Laurent Irakoze
- Astère Manirakiza
- Prudence Bizimana
- Jean Claude Nduwayezu
- Charles Niyomugisha
- Paul Banderembako
- Martin Manirakiza
- Desire Nisubire
- Liliane Nkengurutse
- Guixin Chen
- Qingfeng Cheng
Corresponding author
Correspondence to Qingfeng Cheng.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethic approval and consent to participate
The Ethics Committee of the First Affiliated Hospital of Chongqing Medical University approved this study (number: K2023-537). The experimental procedures were conducted according to Declaration of Helsinki.
Consent to publish
All authors have seen and approved the final version of the manuscript being submitted.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Irakoze, L., Manirakiza, A., Bizimana, P. et al. Levels of Nogo-B in patients with diabetic foot infection: a retrospective study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-81193-7
Received: 07 September 2026
Accepted: 13 November 2026
Published: 19 November 2026
DOI: https://doi.org/10.1038/s41598-026-81193-7
Keywords
来源:Nature 健康护理主题 · nature.com